Overview

September 26 - 27, 2024

National Institutes of Health

Clinical Center
Building 10
10 Center Drive
Bethesda, MD, 20892
Masur Auditorium

This symposium will discuss the development of cell therapy for the treatment of human cancer, from early studies to the current state of the art of basic, clinical, and translational research utilizing T cells, T-cell receptors, and chimeric antigen receptors.

Confirmed Speakers:

James Allison, Ph.D., MD Anderson Cancer Center
Stephanie Goff, M.D., Center for Cancer Research, NCI
Alena Gros, Ph.D., Vall D'Hebon Institute of Oncology
Ken-ichi Hanada, Ph.D., Center for Cancer Research, NCI
Patrick Hwu, M.D., Moffitt Cancer Center
Rosandra Kaplan, M.D., Center for Cancer Research, NCI
Yutaka Kawakami M.D., Ph.D., International University of Health and Welfare
James Kochenderfer, M.D., Center for Cancer Research, NCI
Sri Krishna, Ph.D., Center for Cancer Research, NCI
Michael Lotze, M.D., University of Pittsburgh
Frank Lowery, Ph.D., Center for Cancer Research, NCI
Crystal Mackall, M.D., Stanford University
Richard Morgan, Ph.D., Be Biopharma
James Mule, Ph.D., Moffit Cancer Center 
Maria Parkhurst, Ph.D., Center for Cancer Research, NCI
Crystal Paulos, Ph.D., Winship Cancer Institute at Emory University 
Nicholas Restifo, M.D., Marble Therapeutics
Paul Robbins, Ph.D., Center for Cancer Research, NCI
Steven Rosenberg, M.D., Ph.D., Center for Cancer Research, NCI
Eric Tran, Ph.D., Providence Cancer Institute
Suzanne Topalian, M.D., Johns Hopkins
Jennifer Wargo, M.D., MD Anderson Cancer Center
James Yang, M.D., Center for Cancer Research, NCI